Header cover image

Israeli (TA) Biotech Industry Analysis

UpdatedApr 16, 2024
DataAggregated Company Financials
Companies14
  • 7D-2.6%
  • 3M-14.2%
  • 1Y4.6%
  • YTD-15.6%

Over the last 7 days, the Biotech industry has dropped 5.1%, driven by a pullback from BioLineRx of 17%. Meanwhile, Grace Breeding actually outperformed within the industry, gaining 31% in the last week. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 28% annually.

Industry Valuation and Performance

Has the Israeli Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Apr 2024₪2.1b₪617.8m-₪407,442,389.3021.7x-5.2x3.4x
Fri, 15 Mar 2024₪2.3b₪549.2m-₪369,052,116.5051.5x-6.2x4.2x
Sun, 11 Feb 2024₪2.3b₪585.8m-₪367,427,738.6062.2x-6.3x3.9x
Tue, 09 Jan 2024₪2.4b₪633.4m-₪401,465,932.0062.2x-6x3.8x
Thu, 07 Dec 2023₪2.3b₪632.9m-₪402,445,924.0061.2x-5.8x3.7x
Sat, 04 Nov 2023₪2.1b₪631.9m-₪418,905,864.0073.4x-5.1x3.4x
Mon, 02 Oct 2023₪2.3b₪616.6m-₪411,163,995.0077.6x-5.6x3.8x
Wed, 30 Aug 2023₪1.9b₪615.5m-₪339,272,579.0063.5x-5.6x3.1x
Fri, 28 Jul 2023₪1.9b₪546.6m-₪394,565,528.00n/a-4.8x3.4x
Sun, 25 Jun 2023₪1.9b₪538.1m-₪389,974,817.00n/a-4.9x3.6x
Tue, 23 May 2023₪1.8b₪532.0m-₪372,829,872.00n/a-4.8x3.4x
Thu, 20 Apr 2023₪1.7b₪530.8m-₪372,985,384.00n/a-4.5x3.1x
Sat, 18 Mar 2023₪1.5b₪616.4m-₪436,639,380.004.4x-3.5x2.5x
Mon, 13 Feb 2023₪1.6b₪547.6m-₪471,196,784.004.6x-3.4x2.9x
Wed, 11 Jan 2023₪1.7b₪528.7m-₪471,804,520.0017.5x-3.7x3.3x
Fri, 09 Dec 2022₪1.7b₪478.7m-₪464,485,055.0017.4x-3.6x3.5x
Sun, 06 Nov 2022₪1.8b₪498.7m-₪491,047,657.0018.3x-3.7x3.6x
Tue, 04 Oct 2022₪1.9b₪494.8m-₪488,185,467.0018.2x-3.8x3.8x
Thu, 01 Sep 2022₪2.1b₪454.2m-₪403,350,403.005.5x-5.3x4.7x
Sat, 30 Jul 2022₪2.0b₪489.5m-₪398,262,790.0013.1x-5.1x4.2x
Mon, 27 Jun 2022₪2.1b₪490.0m-₪398,606,401.0012.6x-5.4x4.4x
Wed, 25 May 2022₪2.2b₪484.4m-₪428,794,540.0013.8x-5.2x4.6x
Fri, 22 Apr 2022₪2.9b₪459.0m-₪494,754,511.0014x-5.8x6.2x
Sun, 20 Mar 2022₪2.8b₪459.9m-₪216,873,546.003.2x-12.7x6x
Tue, 15 Feb 2022₪2.9b₪462.7m-₪224,373,652.007.1x-12.8x6.2x
Thu, 13 Jan 2022₪3.7b₪447.7m-₪213,974,892.006.7x-17.1x8.2x
Sat, 11 Dec 2021₪3.6b₪432.8m-₪210,642,012.009.1x-17.2x8.4x
Mon, 08 Nov 2021₪4.1b₪462.1m-₪167,188,635.0010x-24.5x8.9x
Wed, 06 Oct 2021₪4.1b₪476.1m-₪174,435,752.0010.3x-23.6x8.6x
Fri, 03 Sep 2021₪4.3b₪483.2m-₪167,305,098.004x-25.8x8.9x
Sun, 01 Aug 2021₪4.1b₪483.2m-₪167,305,098.004.9x-24.4x8.4x
Wed, 05 May 2021₪4.2b₪528.7m-₪109,530,611.003.6x-38.1x7.9x
Price to Earnings Ratio

-38.1x


Total Market Cap: ₪4.2bTotal Earnings: -₪109,530,611.00Total Revenue: ₪528.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Biotech Industry Price to Earnings3Y Average -10.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Israeli Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.0x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 5.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Israeli Healthcare industry?

IL Market-4.25%
Healthcare-3.28%
Biotech-2.63%
Biotech-2.63%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GRAC Grace Breeding₪11.1031.2%
+₪10.0m
9.1%PS91x
NXTG Nextage Therapeutics₪0.7014.3%
+₪2.8m
44.4%n/a
KDST Kadimastem₪4.892.5%
+₪499.0k
-41.7%PE-1.7x
GFC-M G.F.C Green Fields Capital₪10.900.3%
+₪304.6k
15.9%PE7.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CANF

₪0.028

Can-Fite BioPharma

7D

-3.4%

1Y

33.3%

BONS

₪0.17

Bonus BioGroup

7D

-1.2%

1Y

13.4%

EVGN

₪2.76

Evogene

7D

-3.1%

1Y

26.6%

GFC-M

₪10.90

G.F.C Green Fields Capital

7D

0.3%

1Y

15.9%

XTLB

₪0.10

XTL Biopharmaceuticals

7D

-9.9%

1Y

122.2%

PLNT

₪2.71

PlantArc Bio

7D

-12.1%

1Y

-65.0%

GRAC

₪11.10

Grace Breeding

7D

31.2%

1Y

9.1%

MTLF

₪4.54

Matricelf

7D

-3.6%

1Y

-25.5%

KDST

₪4.89

Kadimastem

7D

2.5%

1Y

-41.7%